
Ziff Davis (ZD) Stock Forecast & Price Target
Ziff Davis (ZD) Analyst Ratings
Bulls say
Ziff Davis is viewed positively because Q2 showed resilient fundamentals: revenue of $286.7M, Adj. EBITDA margin of 26.8%, and EPS of $1.03 were generally in line to slightly above consensus, while free cash flow beat the Street by about $49.6M. The outlook is further supported by management’s disciplined M&A approach, a history of buying sub-scale assets at 2x-3x revenue with 20%+ IRRs, and strategic optionality from ongoing asset monetization. Investors also appear to underappreciate the durability of Health & Wellness, the company’s largest profit engine, and the strengthening Cybersecurity & Martech business, where consumer cybersecurity, IPVanish, SMTP.com, and Semantic Labs are showing momentum.
Bears say
Ziff Davis is facing a negative outlook because its growth model depends heavily on acquisitions that may not succeed, while larger deal sizes could intensify competition and raise execution risk as the company grows. Its core markets are also structurally pressured, with media exposed to dominant online advertising players like Google and Facebook, and the healthcare unit carrying meaningful regulatory risk. The liability for uncertain tax positions increased to 10,383 from 2,167, reinforcing concern over financial complexity, while the company’s leadership and subsidiary structure may slow timely top-down change across the organization.
This aggregate rating is based on analysts' research of Ziff Davis and is not a guaranteed prediction by Public.com or investment advice.
Ziff Davis (ZD) Analyst Forecast & Price Prediction
Start investing in Ziff Davis (ZD)
Order type
Buy in
Order amount
Est. shares
0 shares